PavmedPAVM
13F holders, Q1 2024 (March 31)24holders
$2.13avg. 13F price*
At the end of Q1 2024, 24 institutions reported holding Pavmed Inc. (PAVM) in their 13F filings. The largest holders were First Manhattan Co. Llc. ($910K), Vanguard Group Inc. ($643K) and BlackRock Inc. ($160K).
- Company
- Pavmed Inc.
- CUSIP
- 70387R403
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $10K |
| Exits | 5 | $127K |
Ownership 24 holders
| First Manhattan Co. Llc. | 0.00% | Add +112.5% | 425,000 | $910K |
| Vanguard Group Inc. | 0.00% | Reduce -0.7% | 300,541 | $643K |
| BlackRock Inc. | 0.00% | Reduce -0.0% | 74,912 | $160K |
| Geode Capital Management, LLC | 0.00% | Add +15.0% | 63,360 | $136K |
| State Street Corp. | 0.00% | No change | 20,981 | $45K |
| Valeo Financial Advisors, LLC | 0.00% | No change | 21,129 | $39K |
| Northern Trust Corp. | 0.00% | Reduce -9.3% | 11,752 | $25K |
| XML Financial, LLC | 0.00% | Reduce -2.6% | 10,067 | $22K |
| Wells Fargo & Company | 0.00% | Reduce -37.4% | 7,144 | $15K |
| Morgan Stanley | 0.00% | Add +98.5% | 5,129 | $11K |
| Cwm, LLC | 0.00% | No change | 4,672 | $10K |
| Summit Securities Group LLC | 0.00% | New | 3,612 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -34.9% | 2,457 | $5K |
| CIBC Private Wealth Group LLC | 0.00% | New | 836 | $2K |
| Allworth Financial LP | 0.00% | Reduce -59.0% | 420 | $899 |
| NFSG Corp | 0.00% | New | 134 | $287 |
| Osaic Holdings, Inc. | 0.00% | Reduce -29.7% | 128 | $273 |
| M&R Capital Management Inc. | 0.00% | No change | 67 | $143 |
| JPMorgan Chase & Co. | 0.00% | Add +20.0% | 36 | $78 |
| Bank of America Corp. | 0.00% | Reduce -53.3% | 7 | $15 |
| Thompson Investment Management, Inc. | 0.00% | No change | 4 | $9 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | Reduce -71.0% | 11 | $0 |
| Simplex Trading, LLC | 0.00% | Reduce -59.6% | 400 | $0 |
"% of holder's portfolio" is PAVM's weight in each manager's 13F, not the share of Pavmed Inc. the manager owns.